AI assistant
FREEHILL MINING LIMITED. — Capital/Financing Update 2020
Jan 20, 2020
64918_rns_2020-01-20_ae6303e2-1ed8-4c5e-b3c1-68f02dfbc05d.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity
FREEHILL MINING LIMITED
ABN
27 091 608 025
We (the entity) give ASX the following information.
Part 1 - All issues
You must complete the relevant sections (attach sheets if there is not enough space).
-
1 +Class of +securities issued or to Fully paid ordinary shares. be issued
-
2 Number of[+] securities issued or 30,727,271 to be issued (if known) or maximum number which may be issued
-
3 Principal terms of the[+] securities Fully paid ordinary shares on the same (e.g. if options, exercise price and terms as the existing fully paid ordinary expiry date; if partly paid shares on issue. +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion)
4 Do the[+] securities rank equally in Yes, the shares rank equally with existing all respects from the[+] issue date ordinary shares. with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Shares issued at a price of $0.011 per Share. 6 Purpose of the issue Shares issued to sophisticated and (If issued as consideration for professional investors on conversion of the acquisition of assets, clearly principal of loan amount pursuant to a loan identify those assets) agreement. 6a Is the entity an[+] eligible entity Yes. that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b – 6h in relation to the[+] securities the subject of this Appendix 3B , and comply with section 6i 6b The date the security holder 29 November 2019 resolution under rule 7.1A was passed 6c Number of +securities issued 30,727,271 without security holder approval under rule 7.1 6d Number of +securities issued Nil. with security holder approval under rule 7.1A 6e Number of +securities issued Nil. with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting)
- See chapter 19 for defined terms.
Appendix 3B Page 2
04/03/2013
| 6f Number of +securities issued under an exception in rule 7.2 6g If+securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the+issue date and both values. Include the source of the VWAP calculation. 6h If+securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity’s remaining issue capacity under rule 7.1 and rule 7.1A – complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. |
Nil. |
|---|---|
N/A |
|
| N/A | |
| 7.1 Capacity: 71,761,601 7.1A Capacity: 116,711,890 |
|
| 21 January 2020 |
| 8 Number and +class of all +securities quoted on ASX (including the +securities in section 2 if applicable) |
Number | +Class |
|---|---|---|
| 1,265,065,135 176,481,084 |
Fully Paid Ordinary Shares Options to acquire one fully paid ordinary share each, exercisable at $0.025, expiring on 12November 2021. |
| 9 Number and +class of all +securities not quoted on ASX (including the +securities in section 2 if applicable) 10 Dividend policy (in the case of a trust, distribution policy) on the increased capital (interests) |
Number | +Class |
|---|---|---|
| 1,000,000 | Performance rights issued on 6 February 2017 to the Company COO. |
|
| 1,984,725 | Options exercisable at $0.1425 vesting 16 May 2018 and expiring on 16 May 2023. |
|
| 10,000,000 | Options to acquire one fully paid ordinary share each, exercisable at $0.025, expiring on 12November 2021. |
|
| 30,000,000 | Options exercisable at $0.10 vesting 12 November 2019 and expiring on 12 November 2022. |
|
| The Board of the Company may from time to time determine to distribute the profits of the Company by way of dividend amongst the Shareholders in proportion to the amounts paid up onthe Sharesheld by them. |
- See chapter 19 for defined terms.
Appendix 3B Page 4
04/03/2013
Part 2 - Pro rata issue
| art 2 - Pro rata issue | |
|---|---|
| 11 Is security holder approval required? 12 Is the issue renounceable or non- renounceable? 13 Ratio in which the+securities will be offered 14 +Class of+securities to which the offer relates 15 +Record date to determine entitlements 16 Will holdings on different registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements in relation to fractions 18 Names of countries in which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt of acceptances or renunciations 20 Names of any underwriters 21 Amount of any underwriting fee or commission 22 Names of any brokers to the issue 23 Fee or commission payable to the broker to the issue |
N/A |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
| 24 Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders 25 If the issue is contingent on security holders’ approval, the date of the meeting 26 Date entitlement and acceptance form and offer documents will be sent to persons entitled 27 If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will begin (if applicable) 29 Date rights trading will end (if applicable) 30 How do security holders sell their entitlements_in full_through a broker? 31 How do security holders sell_part_ of their entitlements through a broker and accept for the balance? 32 How do security holders dispose of their entitlements (except by sale through a broker)? 33 +Issue date |
N/A |
|---|---|
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A | |
| N/A |
- See chapter 19 for defined terms.
Appendix 3B Page 6
04/03/2013
Part 3 - Quotation of securities
You need only complete this section if you are applying for quotation of securities
-
34 Type of[+] securities ( tick one )
-
(a) +Securities described in Part 1
-
(b)[All other ][+][securities ]
Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
- 35 If the[+] securities are[+] equity securities, the names of the 20 largest holders of the additional[+] securities, and the number and percentage of additional[+] securities held by those holders
36 If the[+] securities are[+] equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories
1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over
37 A copy of any trust deed for the additional[+] securities
Entities that have ticked box 34(b)
38 Number of[+] securities for which +quotation is sought
39 +Class of +securities for which quotation is sought
40 Do the[+] securities rank equally in all respects from the[+] issue date with an existing[+] class of quoted +securities? If the additional[+] securities do not rank equally, please state: the date from which they do the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment
41 Reason for request for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another[+] security, clearly identify that other[+] security)
Number +Class 42 Number and +class of all +securities quoted on ASX ( including the[+] securities in clause 38)
- See chapter 19 for defined terms.
Appendix 3B Page 8
04/03/2013
Quotation agreement
-
1 +Quotation of our additional +securities is in ASX’s absolute discretion. ASX may quote the[+] securities on any conditions it decides.
-
2 We warrant the following to ASX.
-
The issue of the[+] securities to be quoted complies with the law and is not for an illegal purpose.
-
There is no reason why those[+] securities should not be granted +quotation.
-
An offer of the[+] securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-
Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any[+] securities to be quoted and that no-one has any right to return any[+] securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the[+] securities be quoted.
-
If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the[+] securities be quoted.
-
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
-
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
Sign here: ........................................................... Date: 21 January 2020 Print name: Paul Davies == == == == ==
- See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 9
Appendix 3B – Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for eligible entities
Introduced 01/08/12 Amended 04/03/13
Part 1
Rule 7.1 – Issues exceeding 15% of capital
Step 1: Calculate “A”, the base figure from which the placement capacity is calculated
| Part 1 | Part 1 |
|---|---|
| Rule 7.1 – Issues exceeding 15% of capital | |
| Step 1: Calculate “A”, the base figure from which the placement capacity is calculated |
|
| Insertnumber of fully paid+ordinary securities on issue 12 months before the +issue date or date of agreement to issue |
648,568,352 |
| Addthe following: • Number of fully paid+ordinary securities issued in that 12 month period under an exception in rule 7.2 • Number of fully paid+ordinary securities issued in that 12 month period with shareholder approval • Number of partly paid+ordinary securities that became fully paid in that 12 month period Note: • Include only ordinary securities here – other classes of equity securities cannot be added • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
7,147,058 fully paid ordinary shares (Issued 28 February 2019, Rule 7.2, Exception 4) 3,200,000 fully paid ordinary shares (Issued 28 February 2019, Rule 7.2, Exception 3) 3,967,476 fully paid ordinary shares (Issued 4 March 2019, Rule 7.2, Exception 4) 18,181,731 fully paid ordinary shares (Issued 6 March 2019, Rule 7.2, Exception 4) 20,571,122 fully paid ordinary shares (Issued 8 March 2019, Rule 7.4) 75,686,570 fully paid ordinary shares (Issued 8 March 2019, Rule 7.2, Exception 4) 19,093,800 fully paid ordinary shares (Issued 12 March 2019, Rule 7.2, Exception 4) 8,333,334 fully paid ordinary shares (Issued 12 March 2019, Rule 7.4) 6,000,000 fully paid ordinary shares (Issued 16 April 2019, Rule 7.4) 5,494,506 fully paid ordinary shares (Issued 17 May 2019, Rule 7.2, Exception 4) 287,600,412 fully paid ordinary shares (Issued 12 November 2019, Rule 7.3) 2,142,613 fully paid ordinary shares (Issued 12 November 2019, Rule 7.2, Exception 4) |
- See chapter 19 for defined terms.
Appendix 3B Page 10
04/03/2013
| 34,057,148 fully paid ordinary shares (Issued 14 November 2019, Rule 7.2, Exception 4) 2,572,457 fully paid ordinary shares (Issued 29 November 2019, Rule 7.2, Exception 14) 19,999,997 fully paid ordinary shares (Issued 20 December 2019, Rule 7.3) 4,502,324 fully paid ordinary shares (Issued 20 December 2019, Rule 7.2, Exception 4) |
|
|---|---|
| Subtractthe number of fully paid+ordinary securities cancelled during that 12 month period |
Nil. |
| “A” | 1,167,118,900 |
Step 2: Calculate 15% of “A”
| Step 2: Calculate 15% of “A” | Step 2: Calculate 15% of “A” |
|---|---|
| “B” | 0.15 [Note: this value cannot be changed] |
| Multiply“A” by 0.15 | 175,067,835 |
| Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
30,000 fully paid ordinary shares (8 March 2019) 5,360,000 options exercisable at $0.025 per option, expiring 12 November 2021 (12 November 2019) 44,925,325 fully paid ordinary shares (12 November 2019) 3,000,000 fully paid ordinary shares (3 December 2019) 19,263,638 fully paid ordinary shares (3 January 2020) 30,727,271 fully paid ordinary shares (21 January 2020) |
| “C” | 103,306,234 |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 |
| Step 2: Calculate 15% of “A” | Step 2: Calculate 15% of “A” |
|---|---|
| “B” | 0.15 [Note: this value cannot be changed] |
| Multiply“A” by 0.15 | 175,067,835 |
| Step 3: Calculate “C”, the amount of placement capacity under rule 7.1 that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period_not counting_those issued: • Under an exception in rule 7.2 • Under rule 7.1A • With security holder approval under rule 7.1 or rule 7.4 Note: • This applies to equity securities, unless specifically excluded – not just ordinary securities • Include here (if applicable) the securities the subject of the Appendix 3B to which this form is annexed • It may be useful to set out issues of securities on different dates as separate line items |
30,000 fully paid ordinary shares (8 March 2019) 5,360,000 options exercisable at $0.025 per option, expiring 12 November 2021 (12 November 2019) 44,925,325 fully paid ordinary shares (12 November 2019) 3,000,000 fully paid ordinary shares (3 December 2019) 19,263,638 fully paid ordinary shares (3 January 2020) 30,727,271 fully paid ordinary shares (21 January 2020) |
| “C” | 103,306,234 |
| Step 4: Subtract “C” from [“A” x “B”] to calculate remaining placement capacity under rule 7.1 |
- See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 11
| “A” x 0.15 Note: number must be same as shown in Step 2 |
175,067,835 |
|---|---|
| Subtract“C” Note: number must be same as shown in Step 3 |
103,306,234 |
| Total[“A” x 0.15] – “C” | 71,761,601 [Note: this is the remaining placement capacity under rule 7.1] |
- See chapter 19 for defined terms.
Appendix 3B Page 12
04/03/2013
Part 2
Rule 7.1A – Additional placement capacity for eligible entities
| Part 2 | Part 2 |
|---|---|
| Rule 7.1A – Additional placement capacity for eligible entities | |
| Step 1: Calculate “A”, the base figure from which the placement capacity is calculated |
|
| “A” Note: number must be same as shown in Step 1 of Part 1 |
1,167,118,900 |
| Step 2: Calculate 10% of “A” | |
| “D” | 0.10 Note: this value cannot be changed |
| Multiply“A” by 0.10 | 116,711,890 |
| Step 3: Calculate “E”, the amount of placement capacity under rule 7.1A that has already been used |
|
| Insertnumber of+equity securities issued or agreed to be issued in that 12 month period under rule 7.1A Notes: • This applies to equity securities – not just ordinary securities • Include here – if applicable – the securities the subject of the Appendix 3B to which this form is annexed • Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained • It may be useful to set out issues of securities on different dates as separate line items |
Nil. |
| “E” | 0 |
- See chapter 19 for defined terms.
04/03/2013
Appendix 3B Page 13
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A
| Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
Step 4: Subtract “E” from [“A” x “D”] to calculate remaining placement capacity under rule 7.1A |
|---|---|
| “A” x 0.10 Note: number must be same as shown in Step 2 |
116,711,890 |
| Subtract“E” Note: number must be same as shown in Step 3 |
0 |
| Total[“A” x 0.10] – “E” | 116,711,890 Note: this is the remaining placement capacity under rule 7.1A |
- See chapter 19 for defined terms.
Appendix 3B Page 14
04/03/2013